Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Endo Pharmaceuticals Holdings Inc (ENDP) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Endo Pharmaceuticals Holdings Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1100962.
Total stock buying since 2010: $1,049,610.
Total stock sales since 2010: $21,186,226.
Total stock option exercises since 2010: $11,511,344.
▪ Statistics of price movements of ENDP
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2013 | 6,148 | $220,583 | 320,589 | $12,053,216 | 275,190 | $6,606,667 |
| 2012 | 19,175 | $544,179 | 1,957 | $63,074 | 200,138 | $199,975 |
| 2011 | 8,200 | $248,468 | 148,798 | $5,572,989 | 394,384 | $2,796,341 |
| 2010 | 1,000 | $36,380 | 95,971 | $3,496,947 | 112,882 | $1,908,361 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2013-08 | 5,478 | $199,947 | 145,592 | $5,736,324 | 130,000 | $3,719,300 |
| 2013-04 | 0 | $0 | 173,225 | $6,264,268 | 140,190 | $2,832,117 |
| 2013-03 | 670 | $20,636 | 0 | $0 | 0 | $0 |
| 2013-02 | 0 | $0 | 1,772 | $52,624 | 0 | $0 |
| 2013-01 | 0 | $0 | 0 | $0 | 5,000 | $55,250 |
| 2012-12 | 0 | $0 | 0 | $0 | 173,962 | $0 |
| 2012-11 | 7,425 | $199,287 | 0 | $0 | 9,954 | $199,975 |
| 2012-08 | 0 | $0 | 1,957 | $63,074 | 0 | $0 |
| 2012-06 | 11,750 | $344,892 | 0 | $0 | 0 | $0 |
| 2012-03 | 0 | $0 | 0 | $0 | 13,430 | $0 |
| 2012-02 | 0 | $0 | 0 | $0 | 2,792 | $0 |
| 2011-11 | 0 | $0 | 5,000 | $161,550 | 5,000 | $55,000 |
| 2011-08 | 8,200 | $248,468 | 0 | $0 | 0 | $0 |
| 2011-07 | 0 | $0 | 20,588 | $847,607 | 20,588 | $339,084 |
| 2011-05 | 0 | $0 | 12,500 | $492,375 | 12,500 | $312,750 |
| 2011-04 | 0 | $0 | 35,000 | $1,396,500 | 35,000 | $533,400 |
| 2011-03 | 0 | $0 | 58,103 | $2,085,871 | 53,828 | $621,748 |
| 2011-02 | 0 | $0 | 17,607 | $589,086 | 267,468 | $934,359 |
| 2010-12 | 1,000 | $36,380 | 95,971 | $3,496,947 | 100,948 | $1,908,361 |
| 2010-06 | 0 | $0 | 0 | $0 | 11,934 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-08-26 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Sale | 145,592 | 39.40 | 5,736,324 |
| 2013-08-26 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Option Ex | 130,000 | 28.61 | 3,719,300 |
| 2013-08-08 | Kimmel Roger H (Director) | Buy | 5,478 | 36.50 | 199,947 |
| 2013-04-24 | Gergel Ivan P. (EVP, R&D and CSO) | Sale | 138,225 | 36.46 | 5,039,268 |
| 2013-04-24 | Gergel Ivan P. (EVP, R&D and CSO) | Option Ex | 105,190 | 21.85 | 2,298,717 |
| 2013-04-09 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Sale | 35,000 | 35.00 | 1,225,000 |
| 2013-04-09 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Option Ex | 35,000 | 15.24 | 533,400 |
| 2013-03-05 | Nash David (Director) | Buy | 670 | 30.80 | 20,636 |
| 2013-02-28 | Rudio Daniel (Vice President, Controller) | Sale | 520 | 30.91 | 16,073 |
| 2013-02-27 | Rudio Daniel (Vice President, Controller) | Sale | 770 | 29.88 | 23,007 |
| 2013-02-21 | Rudio Daniel (Vice President, Controller) | Sale | 482 | 28.10 | 13,544 |
| 2013-01-18 | Hyatt Michael (Director) | Option Ex | 5,000 | 11.05 | 55,250 |
| 2012-12-31 | Holveck David (President & CEO) | Option Ex | 89,155 | .00 | 0 |
| 2012-12-31 | Gergel Ivan P. (EVP, Research & Development) | Option Ex | 33,271 | .00 | 0 |
| 2012-12-31 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Option Ex | 19,513 | .00 | 0 |
| 2012-12-31 | Levin Alan G (EVP, Chief Financial Officer) | Option Ex | 32,023 | .00 | 0 |
| 2012-11-15 | Levin Alan G (EVP, Chief Financial Officer) | Option Ex | 9,954 | 20.09 | 199,975 |
| 2012-11-12 | Holveck David (President & CEO) | Buy | 7,425 | 26.84 | 199,287 |
| 2012-08-10 | Rudio Daniel (Vice President, Controller) | Sale | 1,957 | 32.23 | 63,074 |
| 2012-06-15 | Levin Alan G (EVP, Chief Financial Officer) | Buy | 3,200 | 29.68 | 94,976 |
| 2012-06-12 | Holveck David (President & CEO) | Buy | 8,550 | 29.23 | 249,916 |
| 2012-03-15 | Mchugh Julie (Chief Operating Officer) | Option Ex | 3,511 | .00 | 0 |
| 2012-03-12 | Hutson Nancy J (Director) | Option Ex | 1,417 | .00 | 0 |
| 2012-03-12 | Scodari Joseph C (Director) | Option Ex | 1,417 | .00 | 0 |
| 2012-03-12 | Spengler William (Director) | Option Ex | 1,417 | .00 | 0 |
| 2012-03-12 | Delucca John (Director) | Option Ex | 1,417 | .00 | 0 |
| 2012-03-12 | Montague William P (Director) | Option Ex | 1,417 | .00 | 0 |
| 2012-03-12 | Hyatt Michael (Director) | Option Ex | 1,417 | .00 | 0 |
| 2012-03-12 | Kimmel Roger H (Director) | Option Ex | 1,417 | .00 | 0 |
| 2012-02-21 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Option Ex | 2,792 | .00 | 0 |
| 2011-11-08 | Hyatt Michael (Director) | Sale | 5,000 | 32.31 | 161,550 |
| 2011-11-08 | Hyatt Michael (Director) | Option Ex | 5,000 | 11.00 | 55,000 |
| 2011-08-25 | Holveck David (President & CEO) | Buy | 8,200 | 30.30 | 248,468 |
| 2011-07-06 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Sale | 20,588 | 41.17 | 847,607 |
| 2011-07-06 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Option Ex | 20,588 | 16.47 | 339,084 |
| 2011-05-03 | Gergel Ivan P. (EVP, Research & Development) | Sale | 12,500 | 39.39 | 492,375 |
| 2011-05-03 | Gergel Ivan P. (EVP, Research & Development) | Option Ex | 12,500 | 25.02 | 312,750 |
| 2011-04-05 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Sale | 35,000 | 39.90 | 1,396,500 |
| 2011-04-05 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Option Ex | 35,000 | 15.24 | 533,400 |
| 2011-03-30 | Hutson Nancy J (Director) | Option Ex | 1,954 | .00 | 0 |
| 2011-03-15 | Mchugh Julie (Chief Operating Officer) | Option Ex | 3,511 | .00 | 0 |
| 2011-03-14 | Hutson Nancy J (Director) | Option Ex | 1,417 | .00 | 0 |
| 2011-03-14 | Scodari Joseph C (Director) | Option Ex | 3,426 | .00 | 0 |
| 2011-03-14 | Spengler William (Director) | Option Ex | 3,426 | .00 | 0 |
| 2011-03-14 | Delucca John (Director) | Option Ex | 3,426 | .00 | 0 |
| 2011-03-14 | Montague William P (Director) | Option Ex | 3,426 | .00 | 0 |
| 2011-03-14 | Hyatt Michael (Director) | Option Ex | 3,426 | .00 | 0 |
| 2011-03-14 | Kimmel Roger H (Director) | Option Ex | 3,426 | .00 | 0 |
| 2011-03-03 | Sweeney Edward J (Principal Accounting Officer) | Sale | 26,390 | 36.08 | 952,230 |
| 2011-03-03 | Sweeney Edward J (Principal Accounting Officer) | Option Ex | 26,390 | 23.56 | 621,748 |
| 2011-03-02 | Gergel Ivan P. (EVP, Research & Development) | Sale | 30,603 | 35.77 | 1,094,669 |
| 2011-03-01 | Sweeney Edward J (Principal Accounting Officer) | Sale | 1,110 | 35.11 | 38,972 |
| 2011-02-28 | Sweeney Edward J (Principal Accounting Officer) | Option Ex | 1,110 | .00 | 0 |
| 2011-02-28 | Gergel Ivan P. (EVP, Research & Development) | Option Ex | 30,603 | 19.93 | 609,917 |
| 2011-02-24 | Gergel Ivan P. (EVP, Research & Development) | Sale | 15,742 | 33.59 | 528,773 |
| 2011-02-24 | Gergel Ivan P. (EVP, Research & Development) | Option Ex | 15,742 | 20.61 | 324,442 |
| 2011-02-23 | Mchugh Julie (Chief Operating Officer) | Option Ex | 31,490 | .00 | 0 |
| 2011-02-23 | Holveck David (President & CEO) | Option Ex | 103,826 | .00 | 0 |
| 2011-02-23 | Gergel Ivan P. (EVP, Research & Development) | Option Ex | 26,632 | .00 | 0 |
| 2011-02-23 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Option Ex | 23,464 | .00 | 0 |
| 2011-02-23 | Levin Alan G (EVP, Chief Financial Officer) | Option Ex | 32,736 | .00 | 0 |
| 2011-02-21 | Sweeney Edward J (Principal Accounting Officer) | Sale | 695 | 32.34 | 22,476 |
| 2011-02-21 | Sweeney Edward J (Principal Accounting Officer) | Option Ex | 695 | .00 | 0 |
| 2011-02-19 | Sweeney Edward J (Principal Accounting Officer) | Sale | 1,170 | 32.34 | 37,837 |
| 2011-02-19 | Sweeney Edward J (Principal Accounting Officer) | Option Ex | 1,170 | .00 | 0 |
| 2010-12-10 | Kimmel Roger H (Director) | Sale | 13,741 | 36.55 | 502,233 |
| 2010-12-10 | Kimmel Roger H (Director) | Option Ex | 13,741 | 14.16 | 194,531 |
| 2010-12-07 | Hutson Nancy J (Director) | Buy | 1,000 | 36.38 | 36,380 |
| 2010-12-07 | Levin Alan G (EVP, Chief Financial Officer) | Sale | 16,627 | 36.04 | 599,237 |
| 2010-12-07 | Levin Alan G (EVP, Chief Financial Officer) | Option Ex | 21,604 | 18.30 | 395,353 |
| 2010-12-03 | Gergel Ivan P. (EVP, Research & Development) | Sale | 55,603 | 36.53 | 2,031,177 |
| 2010-12-03 | Gergel Ivan P. (EVP, Research & Development) | Option Ex | 55,603 | 22.48 | 1,249,677 |
| 2010-12-03 | Hyatt Michael (Director) | Sale | 10,000 | 36.43 | 364,300 |
| 2010-12-03 | Hyatt Michael (Director) | Option Ex | 10,000 | 6.88 | 68,800 |
| 2010-06-28 | Scodari Joseph C (Director) | Option Ex | 1,059 | .00 | 0 |
| 2010-06-01 | Levin Alan G (EVP, Chief Financial Officer) | Option Ex | 10,875 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of ENDP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Endo Pharmaceuticals Holdings Inc (symbol ENDP, CIK number 1100962) see the Securities and Exchange Commission (SEC) website.